Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.
Derdelinckx
Inge
I
University Medical Center, Eijkman Winkler Institute, Department of Virology, Utrecht, Netherlands.
Wainberg
Mark A
MA
Lange
Joep M A
JM
Hill
Andrew
A
Halima
Yasmin
Y
Boucher
Charles A B
CA
D019380:Anti-HIV Agents / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000191:economics / Q000592:standards* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D012107:Research Design
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D004338:Drug Combinations; D019259:Lamivudine